Join experts with Smartweave on January 15, 2026 for an exclusive look at how the company is transforming cardiac repair and valve replacement with advanced biomaterials, stem cells and AI-guided, patient-specific implants.
This session reveals how Smartweave’s regenerative platform could provide truly restorative solutions to patients with cardiac injuries, malformations or valvular disease—and how investors can participate as the company grows in parallel with its raise on WeFunder.
You’ll learn:
How Smarteave plans to produce personalized valve replacements.
How scaffolds can guide the regrowth of damaged cardiac tissue.
How patient specific stem cells can be used to reproduce physiological function.
The scale of the cardiac repair and valve replacement opportunity—and why timing matters.
How to participate as an early backer of this technology.
